Riskpilot← Back to searchSign inGet full accessMYRASTIEN AS
ASActiveOrg 923792864Bellevue 22, 1606 FredrikstadRental and operating of own or leased real estate · NACE 6820Est. 20190 employees
Revenue 2024
NOK 0
EBITDA margin
—
+65% vs 2023
Equity ratio
42.0%
Financial strength
Net profit 2024
NOK 51K
-99% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -23K | +65% |
| Net profit | NOK 51K | -99% |
| Total assets | NOK 8,7M | -45% |
| Equity | NOK 3,7M | -65% |
| Employees | 0 | — |
Legal name
MYRASTIEN AS
Org number
923792864
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
12. november 2019
Share capital
NOK 480 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Investering i fast eiendom og i aksjer i andre selskaper.
Address
Bellevue 22, 1606 Fredrikstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −55 | −31 | −35 | −50 | −66 | −23 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −55 | −31 | −35 | −50 | −66 | −23 |
| Net financials | −28 | 3 582 | 14 784 | 1 778 | 10 305 | 89 |
| Profit before tax | −83 | 3 551 | 14 748 | 1 729 | 10 240 | 66 |
| Tax | −11 | 14 | 88 | −58 | 80 | 15 |
| Net profit | −72 | 3 537 | 14 661 | 1 787 | 10 160 | 51 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 11 480 | 14 115 | 23 754 | 18 285 | 15 874 | 8 740 |
| Equity | 8 425 | 8 962 | 14 623 | 9 410 | 10 452 | 3 672 |
| Long-term debt | 52 | 41 | 83 | 24 | 21 | 17 |
| Short-term debt | 3 004 | 5 111 | 9 049 | 8 851 | 5 400 | 5 051 |
| Total debt | 3 056 | 5 153 | 9 132 | 8 876 | 5 422 | 5 068 |
EBITDA margin
-2278100.0%
This company
15.8%
Market median
-14418454% vs market
20192024
Equity ratio
42.0%
This company
38.2%
Market median
+10% vs market
20192024
Return on equity
1.4%
This company
18.4%
Market median
-92% vs market
20192024
Net profit margin
5149000.0%
This company
8.1%
Market median
+63567801% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
1.38×
This company
0.62×
Market median
-123% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MYRASTIEN AS (this company)
Jensen & Scheele AsBoard members of MYRASTIEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Beate Scheele | Board of Directors | 0 companies |
| Arne-Henning Scheele | Chairman | 0 companies |